Nkure Therapeutics - biotechnology firm
Nkure Therapeutics is a pioneering biotech platform for development of Natural Killer (NK) cell therapies for cancer treatment. Their mission is to make cutting-edge and affordable immunotherapies accessible, with a focus on improving patient outcomes and extending Indian innovation globally.
BioPharmaAPAC
May 8, 2025
India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics
Strategic collaboration to co-develop CTX112™ aims to address India’s growing burden of B-cell lymphomas with an off-the-shelf, CRISPR-engineered cell therapy offering scalable production and reduced treatment delays.
Economic Times
April 27, 2023
Nkure raises pre-Series A round
The company is pioneering affordable NK cell therapy for the treatment of Cancer. Nkure is scaling rapidly from its first year of inception having successfully developed an NK cell platform at laboratory scale coupled with agreements with CDMOs in India and the US. It has also secured exclusive licenses to a specialized CAR and related technologies to enable allogenic cell therapy, the first of its kind in India.
